GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Market Closed 04-17 16:00:00 EDT

35.93

+0.56

+1.58%

盘后36.00

+0.07+0.19%

19:32 EDT

High36.11	Low35.08	Vol4.81M
Open35.15	D1 Closing35.37	Amplitude2.91%
Mkt Cap72.86B	Tradable Cap70.48B	Total Shares2.03B
T/O172.28M	T/O Rate0.25%	Tradable Shares1.96B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":35.93,"timestamp":1744920000000,"preClose":35.37,"halted":0,"volume":4813943,"hourTrading":{"tag":"盘后","latestPrice":36,"preClose":35.93,"latestTime":"19:32 EDT","volume":42472,"amount":1526012.22,"timestamp":1744932778691},"delay":0,"floatShares":1961688393,"shares":2027868280,"eps":1.557394,"marketStatus":"Market Closed","change":0.56,"latestTime":"04-17 16:00:00 EDT","open":35.15,"high":36.11,"low":35.08,"amount":172275634.60817197,"amplitude":0.029121,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.557394,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":35.37,"dividendRate":0.04515,"preHourTrading":{"tag":"盘前","latestPrice":35.18,"preClose":35.37,"latestTime":"09:29 EDT","volume":27428,"amount":966278.8950560001,"timestamp":1744896575805},"postHourTrading":{"tag":"盘后","latestPrice":36,"preClose":35.93,"latestTime":"19:32 EDT","volume":42472,"amount":1526012.22,"timestamp":1744932778691},"volumeRatio":0.8007106031074462,"impliedVol":0.3814,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"2528135727","title":"GSK Says Health Canada Approves Expanded Jemperli Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2528135727","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528135727?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 02:51","pubTimestamp":1744915894,"startTime":"0","endTime":"0","summary":"GSK (GSK) said Thursday Health Canada has approved Jemperli for use in combination with chemotherapy to treat adults with primary advanced or first recurrent endometrial cancer.The approval broadens t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","BK4532","BK4588","LU1829250122.USD","GSK","BK4007","BK4585"],"gpt_icon":0},{"id":"2528722724","title":"GSK Pharma put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2528722724","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528722724?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 01:55","pubTimestamp":1744912513,"startTime":"0","endTime":"0","summary":"Bearish flow noted in GSK (GSK) Pharma with 3,615 puts trading, or 1.6x expected. Most active are May-25 30 puts and Aug-25 35 puts, with total vol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-pharma-put-volume-heavy-and-directionally-bearish-23?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-pharma-put-volume-heavy-and-directionally-bearish-23?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1829250122.USD","BK4585","GSK","BK4532","GSK.UK","BK4588"],"gpt_icon":0},{"id":"2528761728","title":"GSK Gets UK Approval for Blenrep Combinations in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2528761728","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528761728?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 00:04","pubTimestamp":1744905889,"startTime":"0","endTime":"0","summary":"GSK  said Thursday the UK's Medicines and Healthcare products Regulatory Agency has authorized the use of Blenrep combinations to treat relapsed or refractory multiple myeloma.Blenrep is now approved for the treatment of adults with multiple myeloma in combination with bortezomib and dexamethasone in patients who have received at least one prior therapy, GSK said.The regulator also approved the drug in combination with pomalidomide and dexamethasone in patients who have received at least one prior therapy, including lenalidomide, it added.This authorization marks the first in the world for Blenrep in this treatment setting, the company said.Price: 35.76, Change: +0.39, Percent Change: +1.09","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","GSK","BK4532","BK4585","GSK.UK","BK4007","BK4588"],"gpt_icon":0},{"id":"2528286057","title":"Alector Completes Enrollment for Phase 2 Alzheimer's Trial of AL101","url":"https://stock-news.laohu8.com/highlight/detail?id=2528286057","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528286057?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 00:01","pubTimestamp":1744905676,"startTime":"0","endTime":"0","summary":"Alector (ALEC) said Thursday it has completed enrollment for PROGRESS-AD, a 76-week phase 2 trial assessing the safety and effectiveness of AL101/GSK4527226 in slowing early-stage Alzheimer's disease ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","GSK.UK","BK4139","BK4588","GSK","BK4007","LU1829250122.USD","BK4585","ALEC"],"gpt_icon":0},{"id":"2528769747","title":"GSK reports Blenrep combinations approved by MHRA","url":"https://stock-news.laohu8.com/highlight/detail?id=2528769747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528769747?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 23:20","pubTimestamp":1744903223,"startTime":"0","endTime":"0","summary":"GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is approved fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-reports-blenrep-combinations-approved-by-mhra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-reports-blenrep-combinations-approved-by-mhra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","LU1829250122.USD","GSK.UK","BK4585","BK4588","BK4007","BK4532"],"gpt_icon":0},{"id":"2528742231","title":"GSK’s Blenrep Combinations Approved in UK for Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2528742231","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528742231?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 23:17","pubTimestamp":1744903079,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced the UK MHRA’s approval of Blenrep combinations for treating relapsed/...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-blenrep-combinations-approved-in-uk-for-multiple-myeloma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-blenrep-combinations-approved-in-uk-for-multiple-myeloma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1829250122.USD","BK4532","BK4588","GSK.UK","BK4585","GSK"],"gpt_icon":0},{"id":"2528741330","title":"GSK Executives Increase Share Interests Following Dividend Reinvestment","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528741330?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 22:32","pubTimestamp":1744900362,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK plc has announced an increase in notional interest in its ordinary shares for sever...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-increase-share-interests-following-dividend-reinvestment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-increase-share-interests-following-dividend-reinvestment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1829250122.USD","BK4007","GSK","GSK.UK","BK4585","BK4588"],"gpt_icon":0},{"id":"2528209335","title":"GSK Says CDC Panel Recommends Penmenvy for Adolescent Meningococcal Vaccination","url":"https://stock-news.laohu8.com/highlight/detail?id=2528209335","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528209335?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 05:41","pubTimestamp":1744839660,"startTime":"0","endTime":"0","summary":"GSK said a Centers for Disease Control and Prevention advisory board called for its drug Penmenvy to be part of the adolescent meningococcal vaccination schedule.Penmenvy was recommended to help protect people who are more than 10 years old against disease-causing serogroups of Neisseria meningitidis, as an alternative to the administration of several separate vaccinations, GSK said Wednesday. The recommendation will be reviewed and if adopted would allow for vaccination in fewer doses, which may simplify delivery and improve immunization rates, GSK added.In February, the Food and Drug Administration approved the company's MenABCWY vaccine for use in individuals aged 10 through 25 years.Vaccine doses will be ready for use in the U.S. in summer, GSK said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","CDC","BK4532","BK4585","BK4007","LU1829250122.USD","BK4588","GSK.UK"],"gpt_icon":0},{"id":"2528094272","title":"GSK ‘pleased’ ACIP voted in favor of using RSV vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2528094272","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528094272?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 05:40","pubTimestamp":1744839610,"startTime":"0","endTime":"0","summary":"GSK (GSK) said it is “pleased” that the Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines includi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-pleased-acip-voted-in-favor-of-using-rsv-vaccines?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-pleased-acip-voted-in-favor-of-using-rsv-vaccines?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4585","BK4532","LU1829250122.USD","GSK","BK4007","BK4588"],"gpt_icon":0},{"id":"2528357209","title":"AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices","url":"https://stock-news.laohu8.com/highlight/detail?id=2528357209","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528357209?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 05:36","pubTimestamp":1744839360,"startTime":"0","endTime":"0","summary":"Over 13 million adults aged 50-59 at increased risk in the US can potentially benefit from RSV immunization1. RSV causes an estimated 42,000 hospitalizations* each year in adults aged 50-64 years old in the US2. PHILADELPHIA, April 16, 2025----GSK plc  is pleased that the Advisory Committee on Immunization Practices  voted in favor of recommending the use of RSV vaccines including GSK’s AREXVY  in adults aged 50-59 who are at increased risk for severe RSV disease. This includes people with conditions like COPD, asthma, diabetes, heart disease and those in residential care3. This expands on ACIP’s previous vote in June 2024 to recommend RSV vaccines for adults aged 60-74 who are at increased risk and all adults aged 75 and older. AREXVY is indicated for the prevention of lower respiratory tract disease  caused by RSV in individuals 60 years of age and older, as well as individuals 50 through 59 years of age who are at increased risk for LRTD caused by RSV.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arexvy-recommended-adults-aged-50-213600054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","GSK.UK","BK4588","GSK","BK4007","LU1829250122.USD","BK4585","CDC"],"gpt_icon":0},{"id":"2528220582","title":"GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices","url":"https://stock-news.laohu8.com/highlight/detail?id=2528220582","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528220582?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 04:57","pubTimestamp":1744837020,"startTime":"0","endTime":"0","summary":"Vaccine recommended to help protect persons over 10 years old in the United States  against disease-causing serogroups of Neisseria meningitidis . Broad serogroup coverage in one vaccine reduces injections to help improve vaccination rates and help protect more US adolescents and young adults. PHILADELPHIA, April 16, 2025----GSK plc  today announced that the US Centers for Disease Control and Prevention’s  Advisory Committee on Immunization Practices  has voted to recommend use of PENMENVY  as part of the adolescent meningococcal vaccination schedule. Recommendations made by the ACIP are reviewed and, if adopted, are published as official CDC recommendations.IMD is an uncommon but serious illness that can lead to death for up to one in ten of those who contract it in as little","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gsk-5-1-meningococcal-vaccine-205700566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4532","BK4007","LU1829250122.USD","BK4588","GSK","GSK.UK","CDC"],"gpt_icon":0},{"id":"2527440490","title":"BNP Paribas Initiates GSK at Neutral Rating, $35.25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2527440490","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527440490?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 00:33","pubTimestamp":1744734834,"startTime":"0","endTime":"0","summary":"Price: 35.71, Change: +0.43, Percent Change: +1.22","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK"],"gpt_icon":0},{"id":"2527250496","title":"Market Chatter: China's New Tariffs to Affect US-Made Drugs, Increase Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527250496","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527250496?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 18:54","pubTimestamp":1744714458,"startTime":"0","endTime":"0","summary":"Multiple US-manufactured medicines, including treatments for cancer and diabetes, are now subject to new Chinese tariffs that could increase drugmakers' costs, Reuters reported Tuesday, citing regulatory filings from China.According to records from China's National Medical Products Administration, pharmaceutical firms like AstraZeneca , Eli Lilly , Sanofi , and GSK  produce drugs in the US that are sold in China, the report said.Industry analysts warn that additional costs resulting from these tariffs may either raise prices or reduce the availability of specific drugs in China, as shifting production locations would be challenging in the short term, the report said.The US government is also investigating whether pharmaceutical imports pose a national security risk, which could result in increased duties on foreign drugs, the report said.AstraZeneca, Eli Lilly, Sanofi, and GSK did not immediately respond to MT Newswires' request for comment.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0096364046.USD","IE0002141913.USD","BK4568","LU0256863811.USD","BK4532","LU2063271972.USD","LU0672654240.SGD","LU1366192091.USD","LU1988902786.USD","LU1057294990.SGD","LLY","LU2468319806.SGD","LU1035775433.USD","SG9999017495.SGD","LU0471298777.SGD","LU1868836757.USD","LU1069344957.HKD","LU0256863902.USD","LU2361044949.HKD","LU2265009873.SGD","LU0689472784.USD","LU2361044865.SGD","SG9999015986.USD","LU1280957306.USD","LU1720051017.SGD","IE00BFXG1179.USD","LU0061475181.USD","LU0466842654.USD","SGXZ51526630.SGD","LU1267930730.SGD","LU0882574139.USD","SG9999018865.SGD","LU2106854487.HKD","SG9999014906.USD","AZN","LU2750360997.AUD","SNY","LU0058720904.USD","LU2360106947.USD","SG9999001176.SGD","GSK.UK","LU0079474960.USD","LU1868836591.USD","GSK","LU2471134523.USD","LU0198837287.USD","LU1551013342.USD","LU2237443978.SGD","IE00BJT1NW94.SGD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2527467116","title":"U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2527467116","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527467116?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 17:55","pubTimestamp":1744710900,"startTime":"0","endTime":"0","summary":"0955 GMT - A U.S. investigation into pharmaceutical imports and potential tariffs in the coming months will likely limit clarity from pharma companies during their 1Q results, Barclays analysts say in a note. The investigation, initiated April 1, aims to assess the national security implications of pharmaceutical imports, including finished generics, nongenerics and active pharmaceutical ingredients, and has to be finalized in around nine months. \"With Pharma having been excluded from the initial reciprocal tariffs and it being our house view that some sort of Commerce Department investigation being required for these sectoral tariffs, this isn't too surprising but at least provides some timing framing,\" they say. Barclays analysts estimate that AstraZeneca, Roche and Grifols appear most insulated, whereas GSK and Sandoz look most exposed to a potential tariff risk. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","LU1829250122.USD","LU0109394709.USD","BK4568","BK4532","LU2236285917.USD","LU2462157665.USD","AZN","LU2456880835.USD","BK4007","LU0320765992.SGD","BK4588","BK4156","GRFS","GSK","LU2417539215.USD","BK4585","BK4139","LU0889565916.HKD","GSK.UK","RHHBY"],"gpt_icon":0},{"id":"2527196254","title":"GSK Directors Acquire Shares Through Dividend Reinvestment","url":"https://stock-news.laohu8.com/highlight/detail?id=2527196254","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527196254?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 22:32","pubTimestamp":1744641153,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an update. GSK plc announced the acquisition of American Depositary Shares (ADSs) by several of its indepe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-directors-acquire-shares-through-dividend-reinvestment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-directors-acquire-shares-through-dividend-reinvestment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","BK4007","LU1829250122.USD","BK4588","GSK","GSK.UK"],"gpt_icon":0},{"id":"2527716199","title":"GSK Enhances Shareholder Value with Continued Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2527716199","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527716199?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 14:17","pubTimestamp":1744611422,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK plc announced the purchase of 1,286,688 of its own ordinary shares as part of its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-enhances-shareholder-value-with-continued-buyback-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-enhances-shareholder-value-with-continued-buyback-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4585","GSK.UK","BK4007","BK4588","GSK","BK4532"],"gpt_icon":0},{"id":"2526969612","title":"GSK Executives Acquire Shares Under Reward Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2526969612","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526969612?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 22:32","pubTimestamp":1744381939,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK announced the acquisition of ordinary shares by several of its top executives unde...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-reward-plan-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-acquire-shares-under-reward-plan-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1829250122.USD","GSK","BK4007","GSK.UK","BK4588","BK4532"],"gpt_icon":0},{"id":"2526165997","title":"GSK CEO says the company can navigate through the tariffs, Bloomberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2526165997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526165997?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 18:16","pubTimestamp":1744366581,"startTime":"0","endTime":"0","summary":"In an interview with Bloomberg, GSK (GSK) CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-ceo-says-the-company-can-navigate-through-the-tariffs-bloomberg-says?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-ceo-says-the-company-can-navigate-through-the-tariffs-bloomberg-says?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4007","LU1829250122.USD","BK4585","GSK","GSK.UK","BK4532"],"gpt_icon":0},{"id":"2526365667","title":"Market Chatter: GSK Prepared for Possible Tariffs During Growing US Trade Tensions","url":"https://stock-news.laohu8.com/highlight/detail?id=2526365667","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526365667?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 18:06","pubTimestamp":1744366011,"startTime":"0","endTime":"0","summary":"GSK CEO Emma Walmsley said the pharmaceutical firm has taken precautionary steps to protect its global operations from possible US tariffs on medicines, Bloomberg News reported Friday, citing an interview held in London.Walmsley told Bloomberg GSK had overhauled its supply chain following the Haleon separation, incorporating backup sourcing to improve operational stability.She also noted that although GSK is headquartered in the UK, the US accounts for the majority of its business, making it a central focus for investment, the news outlet reported.Despite policy uncertainty under President Donald Trump, Walmsley reportedly said the company is committed to maintaining a steady flow of treatments and vaccines to patients.GSK is pursuing expansion in China, especially in infectious disease treatments, but does not manufacture there, limiting its exposure to trade tensions with the US, Bloomberg reported.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","GSK.UK","BK4532","LU1829250122.USD","BK4588","GSK","BK4007"],"gpt_icon":0},{"id":"2526648683","title":"GSK Enhances Buyback Program with New Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2526648683","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526648683?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 14:14","pubTimestamp":1744352088,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has announced the purchase of 864,000 of its own ordinary shares as part of its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-enhances-buyback-program-with-new-share-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-enhances-buyback-program-with-new-share-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK","BK4532","GSK.UK","BK4585","BK4007","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":0.0693},{"period":"1month","weight":-0.1104},{"period":"3month","weight":0.0748},{"period":"6month","weight":-0.068},{"period":"1year","weight":-0.0927},{"period":"ytd","weight":0.0624}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.577778,"avgChangeRate":0.012956},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.001972},{"month":3,"riseRate":0.622222,"avgChangeRate":0.021018},{"month":4,"riseRate":0.652174,"avgChangeRate":0.030433},{"month":5,"riseRate":0.4,"avgChangeRate":-0.008934},{"month":6,"riseRate":0.6,"avgChangeRate":0.011286},{"month":7,"riseRate":0.555556,"avgChangeRate":0.004756},{"month":8,"riseRate":0.577778,"avgChangeRate":0.004428},{"month":9,"riseRate":0.511111,"avgChangeRate":0.004151},{"month":10,"riseRate":0.511111,"avgChangeRate":0.011448},{"month":11,"riseRate":0.466667,"avgChangeRate":0.009663},{"month":12,"riseRate":0.6,"avgChangeRate":0.013955}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction